Reporting Quality of Randomized, Controlled Trials Evaluating Combined Chemoradiotherapy in Nasopharyngeal Carcinoma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To comprehensively assess the reporting quality of randomized, controlled trials (RCTs) in nasopharyngeal carcinoma (NPC), and to identify significant predictors of quality.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Int. J. Radiat. Oncol. Biol. Phys.

Title: International journal of radiation oncology, biology, physics

Publisher: Elsevier BV

ISSN (Electronic): 1879-355X

ISSN (Print): 0360-3016

Publication date (Electronic): May 01 2017

Volume: 98

Issue: 1

Affiliations

[1 ] Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China.

[2 ] Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, People's Republic of China.

[3 ] Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.

[4 ] Department of Radiation Oncology, National Cancer Centre Singapore, Singapore.

[5 ] Department of Radiation Oncology, University of Toronto; Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada.

[6 ] Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.

[7 ] Department of Radiation Oncology, Taichung Veterans General Hospital, Taichung, Taiwan.

[8 ] Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China.

[9 ] Department of Medical Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China.

[10 ] Clinical Trials Centre, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China.

[11 ] Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, People's Republic of China.

[12 ] Department of Radiation Oncology, Sun Yat-sen University Cancer Centre, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre of Cancer Medicine, Guangzhou, People's Republic of China. Electronic address: majun2@mail.sysu.edu.cn.

Article

Publisher Item ID: S0360-3016(17)30276-6

DOI: 10.1016/j.ijrobp.2017.01.214

PubMed ID: 28586958

SO-VID: 17e5a58c-dcfa-4027-8c1e-81f7ee0a9c62

History

Data availability:

Comments

Comment on this article

scite_

Cited by 6

See all cited by